Condition: Asthma
Interventions: Drug: FF/VI 100/25 mcg; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting – verified April 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Dose Proportionality Study: Blood Levels of Fluticasone Furoate (FF) and Vilanterol (VI) Following Different Doses of FF/VI Via an Inhaler
Condition: Asthma
Interventions: Drug: Fluticasone furoate 50 mcg (4 inhalations); Drug: Fluticasone furoate 100 mcg (4 inhalations); Drug: Fluticasone furoate 200 mcg (4 inhalations); Drug: Vilanterol 25 mcg (4 inhalations)
Sponsor: GlaxoSmithKline
Not yet recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days